Head-To-Head Contrast: Harvest Health & Recreation (OTCMKTS:HRVSF) and Amphastar Pharmaceuticals (NASDAQ:AMPH)

Harvest Health & Recreation (OTCMKTS:HRVSF) and Amphastar Pharmaceuticals (NASDAQ:AMPH) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Profitability

This table compares Harvest Health & Recreation and Amphastar Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Harvest Health & Recreation	N/A	N/A	N/A
Amphastar Pharmaceuticals	10.76%	14.98%	6.96%

Earnings & Valuation

This table compares Harvest Health & Recreation and Amphastar Pharmaceuticals”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvest Health & Recreation	N/A	N/A	N/A	N/A	N/A
Amphastar Pharmaceuticals	$719.89 million	1.37	$98.09 million	$1.69	13.72

Amphastar Pharmaceuticals has higher revenue and earnings than Harvest Health & Recreation.

Insider & Institutional Ownership

65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. 29.6% of Amphastar Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Harvest Health & Recreation and Amphastar Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvest Health & Recreation	0	0	0	0	0.00
Amphastar Pharmaceuticals	2	6	0	0	1.75

Amphastar Pharmaceuticals has a consensus price target of $22.50, indicating a potential downside of 2.93%. Given Amphastar Pharmaceuticals’ stronger consensus rating and higher possible upside, analysts clearly believe Amphastar Pharmaceuticals is more favorable than Harvest Health & Recreation.

Summary

Amphastar Pharmaceuticals beats Harvest Health & Recreation on 8 of the 8 factors compared between the two stocks.

About Harvest Health & Recreation

Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.